A. Maiti, “The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin”, J Endocrinol Metab, May 2025, doi: 10.14740/jem1055.